On the public citation graph

Pharmacopolitics: drug regulation in the United States and Germany

https://doi.org/10.5860/choice.42-0332
0 signed · 107 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.1374072openalex-extracted
Where is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location
inferred← citeshttps://doi.org/10.1002/bewi.201001490openalex-snapshot
Psychopharmaka im Sozialismus. Arzneimittelregulierung in der Deutschen Demokratischen Republik in den 1960er Jahren
inferred← citeshttps://doi.org/10.1007/978-0-387-48345-0_11openalex-snapshot
Patenting Biotechnology
inferred← citeshttps://doi.org/10.1007/978-3-319-91788-7_4openalex-snapshot
Epilogue: Opioid Heterotopias
inferred← citeshttps://doi.org/10.1007/978-3-540-78845-4_2openalex-snapshot
Trading in Cold Blood?
inferred← citeshttps://doi.org/10.1007/s00048-013-0101-5openalex-snapshot
„Wunschverordnung“ oder objektiver „Bevölkerungsbedarf“?
inferred← citeshttps://doi.org/10.1007/s00508-018-1343-yopenalex-snapshot
Medical Ethics in the 70 Years after the Nuremberg Code, 1947 to the Present
inferred← citeshttps://doi.org/10.1007/s10460-021-10243-9openalex-snapshot
Policy responses to foodborne disease outbreaks in the United States and Germany
inferred← citeshttps://doi.org/10.1007/s11024-017-9323-3openalex-snapshot
From Regulatory Knowledge to Regulatory Decisions: The European Evaluation of Medicines
inferred← citeshttps://doi.org/10.1007/s11024-017-9324-2openalex-snapshot
Opening the Regulatory Black Box of Clinical Cancer Research: Transnational Expertise Networks and “Disruptive” Technologies
inferred← citeshttps://doi.org/10.1007/s11569-014-0200-3openalex-snapshot
Cultures and Strategies in the Regulation of Nanotechnology in Germany, Austria, Switzerland and the European Union
inferred← citeshttps://doi.org/10.1007/s11609-015-0281-zopenalex-snapshot
Responsibilisierende Entscheidungen. Strategien und Paradoxien des sozialen Umgangs mit probabilistischen Risiken am Beispiel der Medizin
inferred← citeshttps://doi.org/10.1007/s41055-017-0023-3openalex-snapshot
Proportionality in Public Health Regulation: The Case of Dietary Supplements
inferred← citeshttps://doi.org/10.1016/b978-0-08-097086-8.85045-xopenalex-snapshot
Biomedical Sciences, History and Sociology of
inferred← citeshttps://doi.org/10.1016/b978-0-08-097086-8.85054-0openalex-snapshot
Pharmaceutical Industry: Political Economies of Drugs and Knowledge
inferred← citeshttps://doi.org/10.1016/j.atg.2016.09.001openalex-snapshot
Translating genetics beyond bench and bedside: A comparative perspective on health care infrastructures for ‘familial’ breast cancer
inferred← citeshttps://doi.org/10.1016/j.shpsc.2006.12.009openalex-snapshot
Hormones for life? Behind the rise and fall of a hormone remedy (Gonadex) against sterility in the Swedish welfare state
inferred← citeshttps://doi.org/10.1016/j.shpsc.2011.05.005openalex-snapshot
Blockbusters and controlled substances: Miltown, Quaalude, and consumer demand for drugs in postwar America
inferred← citeshttps://doi.org/10.1016/j.socscimed.2015.01.023openalex-snapshot
Neoliberal technocracy: Explaining how and why the US Food and Drug Administration has championed pharmacogenomics
inferred← citeshttps://doi.org/10.1016/j.socscimed.2018.12.025openalex-snapshot
Changing standards for drug approval: A longitudinal analysis of conditional marketing authorisation in the European Union
inferred← citeshttps://doi.org/10.1016/j.yrtph.2005.03.003openalex-snapshot
Assessing prescription medications for priority regulatory review
inferred← citeshttps://doi.org/10.1017/9781108667081openalex-snapshot
The Protective State
inferred← citeshttps://doi.org/10.1017/mdh.2016.2openalex-snapshot
Re-Inventing Infectious Disease: Antibiotic Resistance and Drug Development at the Bayer Company 1945–80
inferred← citeshttps://doi.org/10.1017/s0022216x16001851openalex-snapshot
Drug Wars: Revolution, Embargo, and the Politics of Scarcity in Cuba, 1959–1964
inferred← citeshttps://doi.org/10.1017/s0269889723000133openalex-snapshot
Detecting the unknown in a sea of knowns: Health surveillance, knowledge infrastructures, and the quest for classification egress
inferred← citeshttps://doi.org/10.1017/s0898030617000264openalex-snapshot
Controlling “America’s Opium”: Barbiturate Abuse, Pharmaceutical Regulation, and the Politics of Public Health in the Early Postwar United States
inferred← citeshttps://doi.org/10.1017/s0898588x18000123openalex-snapshot
Pockets of Weakness in Strong Institutions: Post-Marketing Regulation, Psychopharmaceutical Drugs, and Medical Autonomy, 1938–1982
inferred← citeshttps://doi.org/10.1017/s1467222700008314openalex-snapshot
Pharmaceutical Networks: The Political Economy of Drug Development in the United States, 1945–1980
inferred← citeshttps://doi.org/10.1017/s146722270001394xopenalex-snapshot
ESO Volume 5 Issue 4 Front matter
inferred← citeshttps://doi.org/10.1017/s1528887000002561openalex-snapshot
Clinical Trials Abroad: The Marketable Ethics, Weak Protections and Vulnerable Subjects of EU Law
inferred← citeshttps://doi.org/10.1017/s174413310800457xopenalex-snapshot
Global health challenges in the pharmaceutical world
inferred← citeshttps://doi.org/10.1056/nejmsa1007467openalex-snapshot
Innovation, Regulation, and the FDA
inferred← citeshttps://doi.org/10.1057/9781137291523_1openalex-snapshot
General Introduction
inferred← citeshttps://doi.org/10.1057/9781137291523_12openalex-snapshot
Managing Double Binds in the Pharmaceutical Prescription Market: The Case of Halcion
inferred← citeshttps://doi.org/10.1057/9781137291523_2openalex-snapshot
Secrets, Bureaucracy, and the Public: Drug Regulation in Early 19th-Century Prussia
inferred← citeshttps://doi.org/10.1057/9781137291523_5openalex-snapshot
Making Risks Visible: The Science, Politics, and Regulation of Adverse Drug Reactions
inferred← citeshttps://doi.org/10.1057/9781137291523_6openalex-snapshot
Regulating Drugs, Regulating Diseases: Consumerism and the US Tolbutamide Controversy
inferred← citeshttps://doi.org/10.1057/9781137291523_7openalex-snapshot
Thalidomide, Drug Safety Regulation, and the British Pharmaceutical Industry: The Case of Imperial Chemical Industries
inferred← citeshttps://doi.org/10.1057/9781137291523_8openalex-snapshot
What’s in a Pill? On the Informational Enrichment of Anti-Cancer Drugs
inferred← citeshttps://doi.org/10.1057/9781137542472_5openalex-snapshot
Sex Hormones for Animals and Humans? Enhancement and the Public Expertise of Drugs in Post-war United States and France
inferred← citeshttps://doi.org/10.1057/biosoc.2010.39openalex-snapshot
Making medicines essential: The emergent centrality of pharmaceuticals in global health
inferred← citeshttps://doi.org/10.1057/biosoc.2011.19openalex-snapshot
Constructing embryos, constructing politics: Connecting politics and technology in the Netherlands and Germany
inferred← citeshttps://doi.org/10.1080/07341510903083237openalex-snapshot
Synthesis by microbes or chemists? Pharmaceutical research and manufacturing in the antibiotic era
inferred← citeshttps://doi.org/10.1080/07341512.2013.828509openalex-snapshot
‘Doriden von Ciba’: sleeping pills, pharmaceutical marketing, and Thalidomide, 1955–1963
inferred← citeshttps://doi.org/10.1080/09505430500042056openalex-snapshot
Utopian dreams and regulatory nightmares
inferred← citeshttps://doi.org/10.1080/09505431.2015.1079605openalex-snapshot
Resilience in Scientific Research: Understanding How Natural Product Research Rebounded in an Adverse Situation
inferred← citeshttps://doi.org/10.1080/09555803.2015.1040819openalex-snapshot
Medicating the salaryman lifestyle: fear-based marketing of liver stimulant drugs in postwar Japan
inferred← citeshttps://doi.org/10.1080/09692290.2015.1066695openalex-snapshot
The tools of globalization: ways of regulating and the structure of the international regime for pharmaceuticals
inferred← citeshttps://doi.org/10.1080/13511610.2012.723881openalex-snapshot
Cardiac stem cell research: regulation and practice in the UK and Germany
inferred← citeshttps://doi.org/10.1080/13698575.2011.596191openalex-snapshot
A comparative analysis of risk management strategies in European Union and United States pharmaceutical regulation
inferred← citeshttps://doi.org/10.1080/13876980500116188openalex-snapshot
Challenges to Regulatory Harmonization and Standard-Setting: The Case of Environmental Accounting in the US and Canada
inferred← citeshttps://doi.org/10.1080/14636778.2010.528191openalex-snapshot
Solidarity in practices of provision: distributing access to genetic technologies in health care in Germany, the Netherlands and the United Kingdom
inferred← citeshttps://doi.org/10.1080/14636778.2013.873336openalex-snapshot
Streitkultur and the governance of genetic testing and insurance in Germany
inferred← citeshttps://doi.org/10.1080/17449359.2013.804417openalex-snapshot
Geneaology of the Pharmacon: new conditions for the social management of the extraordinary
inferred← citeshttps://doi.org/10.1080/17530350.2017.1352010openalex-snapshot
Opiates for the masses: constructing a market for prescription (pain)killers
inferred← citeshttps://doi.org/10.1080/19460171.2015.1024704openalex-snapshot
Constitutions of justice in genetic medicine: distributing diagnostics for familial hypercholesterolemia in three European countries
inferred← citeshttps://doi.org/10.1093/humrep/dep054openalex-snapshot
Providing preimplantation genetic diagnosis in the United Kingdom, The Netherlands and Germany: a comparative in-depth analysis of health-care access
inferred← citeshttps://doi.org/10.1093/jhmas/jrp012openalex-snapshot
"Who's Winning the Human Race?" Cold War as Pharmaceutical Political Strategy
inferred← citeshttps://doi.org/10.1093/jhmas/jrs050openalex-snapshot
Efficacy and Enlightenment: LSD Psychotherapy and the Drug Amendments of 1962
inferred← citeshttps://doi.org/10.1093/jleo/ewp002openalex-snapshot
Early Entrant Protection in Approval Regulation: Theory and Evidence from FDA Drug Review
inferred← citeshttps://doi.org/10.1093/oxfordhb/9780190848927.013.13openalex-snapshot
Experts in the Regulation of Technology and Risk: An Ecological Perspective on Regulatory Science
inferred← citeshttps://doi.org/10.1108/13581981211218289openalex-snapshot
Towards a practical approach to responsible innovation in finance
inferred← citeshttps://doi.org/10.1111/1467-9566.13409openalex-snapshot
A ‘patient–industry complex’? Investigating the financial dependency of UK patient organisations on drug company funding
inferred← citeshttps://doi.org/10.1111/1468-0009.12279openalex-snapshot
Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending
inferred← citeshttps://doi.org/10.1111/j.1468-4446.2012.01424.xopenalex-snapshot
The logic of strategic ignorance
inferred← citeshttps://doi.org/10.1111/soc4.12335openalex-snapshot
Regulating Pharmaceutical Industry Marketing: Development, Enforcement, and Outcome of Marketing Rules
inferred← citeshttps://doi.org/10.1136/medhum-2018-011478openalex-snapshot
Pharmaceuticals and modern statecraft in South Africa: the cases of opium, thalidomide and contraception.
inferred← citeshttps://doi.org/10.1142/s0219747210000075openalex-snapshot
From Decentralised Developmental State Towards Authoritarian Regulatory State: A Case Study on Drug Safety Regulation in China
inferred← citeshttps://doi.org/10.1146/annurev-polisci-050409-113009openalex-snapshot
Is Health Politics Different?
inferred← citeshttps://doi.org/10.1177/009885880503100204openalex-snapshot
Dietary supplement labeling: cognitive biases, market manipulation & consumer choice.
inferred← citeshttps://doi.org/10.1177/0162243907301002openalex-snapshot
Deficits, Expectations and Paradigms in British and American Drug Safety Assessments
inferred← citeshttps://doi.org/10.1177/0162243915570947openalex-snapshot
Regulatory Anatomy
inferred← citeshttps://doi.org/10.1177/0306312705052103openalex-snapshot
The Contract Research Organization and the Commercialization of Scientific Research
inferred← citeshttps://doi.org/10.1177/0306312708101047openalex-snapshot
Ghosts in the Machine
inferred← citeshttps://doi.org/10.1177/0306312708101977openalex-snapshot
Pharmacovigilance and Post-Black Market Surveillance
inferred← citeshttps://doi.org/10.1177/0306312710395341openalex-snapshot
Tradition and toxicity: Evidential cultures in the kava safety debate
inferred← citeshttps://doi.org/10.1177/0306312714520864openalex-snapshot
Neoliberal pharmaceutical science and the Chicago School of Economics
inferred← citeshttps://doi.org/10.1177/0957154x16648822openalex-snapshot
Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration
inferred← citeshttps://doi.org/10.1177/0963662512452231openalex-snapshot
Public understanding of participation in regulatory decision-making: The case of bottled water quality standards in India
inferred← citeshttps://doi.org/10.1177/1350508408100478openalex-snapshot
Informed Consent: The Making of a Ubiquitous Rule in Medical Practice
inferred← citeshttps://doi.org/10.1186/s12992-018-0402-5openalex-snapshot
Transnational pharmacogovernance: emergent patterns in the jazz of pharmaceutical policy convergence
inferred← citeshttps://doi.org/10.1215/03616878-3802953openalex-snapshot
The Politics and Policies of Regulating Generics in Latin America: A Survey of Seventeen States
inferred← citeshttps://doi.org/10.1215/9781478023678-001openalex-snapshot
RX for MX
inferred← citeshttps://doi.org/10.1215/9781478023678-002openalex-snapshot
Same and Not the Same
inferred← citeshttps://doi.org/10.1215/9781478023678-003openalex-snapshot
Simipolitics
inferred← citeshttps://doi.org/10.1215/9781478023678-005openalex-snapshot
Access, Excess
inferred← citeshttps://doi.org/10.1215/9781478023678-006openalex-snapshot
Supergeneric vs. Mere Commodity
inferred← citeshttps://doi.org/10.1215/9781478023678-008openalex-snapshot
Notes
inferred← citeshttps://doi.org/10.12927/hcpol.2013.23621openalex-snapshot
Health Canada and the Pharmaceutical Industry: A Preliminary Analysis of the Historical Relationship
inferred← citeshttps://doi.org/10.1353/bhm.0.0126openalex-snapshot
Allied Against Reform: Pharmaceutical Industry–Academic Physician Relations in the United States, 1945–1970
inferred← citeshttps://doi.org/10.1353/bhm.0.0218openalex-snapshot
Keeping Modern in Medicine: Pharmaceutical Promotion and Physician Education in Postwar America
inferred← citeshttps://doi.org/10.1353/bhm.2005.0173openalex-snapshot
The Great American Medicine Show Revisited
inferred← citeshttps://doi.org/10.1353/bhm.2011.0024openalex-snapshot
Bioequivalence: The Regulatory Career of a Pharmaceutical Concept
inferred← citeshttps://doi.org/10.1353/crv.2013.0007openalex-snapshot
The Maple Peril: From Presidential Policy to Pharmaceutical Importation, 1992-Present
inferred← citeshttps://doi.org/10.1353/tech.2005.0066openalex-snapshot
Antibiotics, Big Business, and Consumers: The Context of Government Investigations into the Postwar American Drug Industry
inferred← citeshttps://doi.org/10.14418/wes01.1.848openalex-snapshot
The Impact of Novel Products on Federal Regulations Controlling Drug Production: 1906-1963
inferred← citeshttps://doi.org/10.1515/zfrs-2017-0003openalex-snapshot
Die Verdinglichung der Dinge
inferred← citeshttps://doi.org/10.1515/zfsoz-2012-0205openalex-snapshot
Soziologie des Pharmazeutischen. Theoretische Erschließung, genealogische Untersuchung, exemplarische Anwendung / Sociology of the Pharmaceutical. Theoretical Exploration, Genealogical Investigation, Exemplary Application
inferred← citeshttps://doi.org/10.2190/hs.42.1kopenalex-snapshot
Harmony in Drug Regulation, but Who's Calling the Tune? An Examination of Regulatory Harmonization in Health Canada
inferred← citeshttps://doi.org/10.23987/sts.55240openalex-snapshot
Lessening the Evils, Online
inferred← citeshttps://doi.org/10.32702/2307-2156.2024.11.12openalex-snapshot
СТАНОВЛЕННЯ ФАРМАЦЕВТИЧНОГО РИНКУ В СТРУКТУРІ НАЦІОНАЛЬНИХ ЕКОНОМІК
inferred← citeshttps://doi.org/10.3280/ses2009-en2014openalex-snapshot
Medicalization and Biomedicalization Revisited: Technoscience and Transformations of Health, Illness and Biomedicine
inferred← citeshttps://doi.org/10.4000/12swoopenalex-snapshot
Des petits nombres à l’amorce d’un scandale sanitaire
inferred← citeshttps://doi.org/10.4000/rac.30640openalex-snapshot
Savoirs et ignorances disputés des médicaments ‘détournés’ en gynécologie-obstétrique
inferred← citeshttps://doi.org/10.7551/mitpress/14926.001.0001openalex-snapshot
Data Paradoxes
inferred← citeshttps://doi.org/10.7551/mitpress/14926.003.0012openalex-snapshot
References
inferred← citeshttps://doi.org/10.82444/warw.33741301openalex-snapshot
Entre oportunidad y riesgo : regulación, expectativas y políticas CTI para células madre en Argentina
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.